HeartSciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HSCS research report →
Range $3 – $3
Price Chart
About the company
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process.
- CEO
- Andrew Simpson
- IPO
- 2022
- Employees
- 14
- HQ
- Southlake, TX, US
Get TickerSpark's AI analysis on HSCS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.14M
- P/E
- -1.18
- PEG
- -0.01
- P/S
- 1801.57
- P/B
- -6.80
- EV/EBITDA
- 1.87
- Div Yield
- 0.00%
- Gross Margin
- -2908.83%
- Op Margin
- -209733.08%
- Net Margin
- -227024.23%
- ROE
- -816.25%
- ROIC
- -480.77%
Latest fiscal year · YoY change
- Revenue
- $4.32K-0.7%
- Gross Profit
- $-128,799-2.6%
- Op Income
- $-8,412,867
- Net Income
- $-9,141,875-4.3%
- EPS
- $-3.48+62.7%
- OCF Growth
- -0.2%
- FCF Growth
- -0.4%
- 52W High
- $5.25
- 52W Low
- $1.63
- 50D MA
- $3.19
- 200D MA
- $2.68
- Beta
- 1.77
- RSI (14)
- 48
- Avg Volume
- 144.42K
No earnings-call transcripts are available for HSCS yet.
- Free Float
- 90.6%
- Shares Outstanding
- 4.84M
- Float Shares
- 1.96M
of shares held by institutions
19 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 6 ETFs
Biggest fund positions in HSCS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 7, 26 | Watson Danielle | other | 25,000 |
| Jun 22, 26 | Simpson Andrew | other | 425,000 |
| Jan 12, 26 | Wells David R. | other | 15,000 |
| Jan 12, 26 | Bent Bruce | other | 15,000 |
| Dec 22, 25 | HILZ MARK T | other | 45,000 |
| Dec 22, 25 | Szymczak Brian | other | 15,000 |
| Dec 22, 25 | Watson Danielle | other | 15,000 |
| Nov 28, 25 | Simpson Andrew | other | 70,000 |
| Jul 29, 25 | HILZ MARK T | sell | 4,416 |
| Jul 9, 25 | Bent Bruce | other | 25,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HSCS coverage
Recent articles, reports, and earnings notes.
No research on HSCS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HSCS report →HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
globenewswire.com · Oct 6
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
businesswire.com · Sep 29
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
globenewswire.com · Sep 15
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
zacks.com · Sep 14
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
globenewswire.com · Aug 19
Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem
gurufocus.com · Jul 30
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
globenewswire.com · Jul 29
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
globenewswire.com · Jul 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.